0
its depend upon the dosage of dopamine given via iv
2 to 5microgram/kg/min called renal dosage it binds to D1 receptor which causes dilation of blood vessel,increasing blood flow to the renal ,mesenteric and coronary arteries
5 to10 microgram/kg/min have positive inotropic and chronotropic effect by acting on beta1 receptor on heart
10 to 20 microgram/kg/min causes vasoconstriction by acting on alpha1 receptor
Still curious? Ask our experts.
Chat with our AI personalities
Lao
Rene
JordanDopamine is a neurotransmitter that acts as both a vasoconstrictor and vasodilator depending on the dose. At low doses, dopamine preferentially dilates blood vessels in the kidneys, mesentery, and heart, while at higher doses, it primarily constricts blood vessels systemically.
Add your answer:
Earn +20 pts
Is O2 a vasoconstrictor?
No, oxygen (O2) is not a vasoconstrictor. In fact, oxygen is crucial for vasodilation, which helps to increase blood flow through the blood vessels. Oxygen plays a vital role in maintaining healthy vascular function.
Why is parkinsons treated with dopamine?
Parkinson's disease is characterized by a lack of dopamine in the brain due to the degeneration of dopamine-producing neurons. Therefore, treatment with dopamine medication helps to alleviate the motor symptoms associated with the disease by increasing dopamine levels in the brain.
Is L-dopa an agonist or antagonist for dopamine?
L-dopa is a precursor that is converted to dopamine in the brain. It is not an agonist or antagonist itself, but once converted to dopamine, it acts as an agonist on dopamine receptors.
What classification of drug is dopamine agonists?
Dopamine agonists are classified as medications that act on dopamine receptors to mimic the effects of dopamine in the brain. They are commonly used in the treatment of conditions such as Parkinson's disease and restless legs syndrome.
Which substance has a chemical composition similar enough to dopamine to allow it to fit the dopamine receptor sites in the brain?
L-dopa is a substance with a chemical composition similar to dopamine that can bind to dopamine receptor sites in the brain. It is commonly used in the treatment of Parkinson's disease to increase dopamine levels.
